Therapy News and Research

RSS

Serial liquid biopsies reveal evolution in advanced prostate cancer

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across therapies.

26 Feb 2026

Extra copies of chromosome 1q may play key role in the earliest stages of pancreatic cancer

Researchers at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center uncovered new evidence that extra copies of a specific chromosome segment - chromosome 1q - may play a key role in the earliest stages of pancreatic cancer development.

26 Feb 2026

Combining stem cell therapy with fetal surgery shows promise for treating myelomeningocele

A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida.

26 Feb 2026

HIT cell therapy eradicates solid tumors in preclinical models

CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers.

26 Feb 2026

Novel lipid bubble delivery shows promise for ALS treatment

A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral sclerosis (ALS), the neurodegenerative disorder commonly known as Lou Gehrig's disease.

26 Feb 2026

Fifteen-year follow up reveals cure potential in follicular lymphoma

Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard regimens of immunotherapy and a chemotherapy combination known as CHOP suggests that many of those patients can now be considered cured.

26 Feb 2026

Ultra-sensitive CAR T cells target solid tumors

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors.

26 Feb 2026

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.

26 Feb 2026

Innovative laser procedure offers new hope for recurrent brain tumors

High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients

26 Feb 2026

Targeting glutamine metabolism offers new hope for synovial sarcoma treatment

Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults.

26 Feb 2026

‘Kind of morbid’: Health premiums threaten their nest egg. A terminal diagnosis may spare it.

Early on, Jean Franklin got some career advice she followed religiously: "Pay yourself first." So she did, socking away hundreds of thousands of dollars in retirement savings by the time she became a stay-at-home mom at age 41.

26 Feb 2026

New daily tablet simplifies long-term HIV care

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet.

26 Feb 2026

New single pill regimen simplifies treatment for resistant HIV

A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and lenacapavir (BIC/LEN) – may simplify treatment significantly for people with HIV who currently take very complex treatments.

25 Feb 2026

Vitamin B3 shows promise for treating rare genetic disorder

Scientists at Gladstone Institutes have flipped the traditional approach to finding potential treatments for deadly diseases.

25 Feb 2026

Disrupted lymphatic vessels may drive chronic organ transplant rejection

Despite advances in the field of organ transplantation, long-term organ rejection that can become apparent a decade or more after a heart or lung transplant remains a common problem for patients.

25 Feb 2026

Next-generation CAR T therapy offers hope but faces clinical challenges

A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment."

25 Feb 2026

Unexpected behavior observed during interactions between immune cells and dying cells

Over the years, cell biology has built a detailed picture of how cells compartmentalize their internal functions. Central to this organization is the nucleus, which houses the genetic material and is separated from the cytoplasm by a robust nuclear envelope.

25 Feb 2026

Breakthrough gene therapy for sickle cell disease remains out of reach in Africa

As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most patients in Africa.

25 Feb 2026

Nearly 6 in 10 women in the U.S. may have cardiovascular disease in the next 25 years

Driven by rising rates in high blood pressure, nearly 6 in 10 women in the U.S. will have some type of cardiovascular disease (CVD) in the next 25 years, according to a new scientific statement published today in Circulation, the peer-reviewed, flagship journal of the American Heart Association, a global force changing the future of health for all.

25 Feb 2026

Hip exoskeleton reduces walking effort in stroke survivors

A leading cause of disability in the United States is hemiparesis, a condition where impaired motor control, muscle weakness, and spasticity affect one side of the body.

24 Feb 2026

Previous
1
...
68
69
70
71
72
73
74
...
2932
Next

Therapy News and Research

Serial liquid biopsies reveal evolution in advanced prostate cancer

Extra copies of chromosome 1q may play key role in the earliest stages of pancreatic cancer

Combining stem cell therapy with fetal surgery shows promise for treating myelomeningocele

HIT cell therapy eradicates solid tumors in preclinical models

Novel lipid bubble delivery shows promise for ALS treatment

Fifteen-year follow up reveals cure potential in follicular lymphoma

Ultra-sensitive CAR T cells target solid tumors

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

Innovative laser procedure offers new hope for recurrent brain tumors

Targeting glutamine metabolism offers new hope for synovial sarcoma treatment

‘Kind of morbid’: Health premiums threaten their nest egg. A terminal diagnosis may spare it.

New daily tablet simplifies long-term HIV care

New single pill regimen simplifies treatment for resistant HIV

Vitamin B3 shows promise for treating rare genetic disorder

Disrupted lymphatic vessels may drive chronic organ transplant rejection

Next-generation CAR T therapy offers hope but faces clinical challenges

Unexpected behavior observed during interactions between immune cells and dying cells

Breakthrough gene therapy for sickle cell disease remains out of reach in Africa

Nearly 6 in 10 women in the U.S. may have cardiovascular disease in the next 25 years

Hip exoskeleton reduces walking effort in stroke survivors

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News